NCT05930236

Brief Summary

The current standard technique is radiography requiring three uni- or bilateral punctures (transverse-axial plane). The ultrasound technique is also described mainly in this plan but a new "caudal-cranial" ultrasound-guided technique was described by Chang et al in 2018 in which the major axis is used to conduct the needle to the desired area. The investigators would like to confirm that this new technique in a single puncture is also possible under ultrasound.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 21, 2023

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

June 22, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

July 5, 2023

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2024

Completed
Last Updated

July 5, 2023

Status Verified

July 1, 2023

Enrollment Period

1.1 years

First QC Date

June 22, 2023

Last Update Submit

July 3, 2023

Conditions

Keywords

PainfluoroscopyUltrasoundInjection Site InfiltrationChronicfacet infiltration

Outcome Measures

Primary Outcomes (1)

  • Correct needle placement rate

    Check the correct placement of the needle placed by caudal-cranial approach by X-ray to show if the placement is correct (at the same time)

    0 min

Secondary Outcomes (2)

  • change in visual analog scale (VAS) pain score

    30 min

  • Incidence of Adverse event

    30 min

Study Arms (1)

ultrasound guided infiltration verified by fluoroscopy

EXPERIMENTAL

The 22G needle is introduced along a caudal-cranial axis to infiltrate at each level a volume of 1mL of a mixture consisting of 3mL of Linisol 2% (60mg of lidocaine) and 1mL of Depomedrol (Methylprednisolone) 40mg with 1mL of Omnipaque (contrast product). At each level, contrast medium will be injected at the same time as the linisol-depomedrol mixture so that once the BBM under ultrasound is completed, an X-ray check is performed.

Diagnostic Test: Lumbar medial branch blockDrug: LidocainDrug: MethylprednisoloneDrug: Omnipaque

Interventions

The lumbar medial branch block on three lumbar levels (L3-L4, L4-L5 and L5-S1) will be performed by ultrasound-guidance in a longitudinal plane and the correct placement of the needle will be verified by radiography to show if the two modalities are equivalent.

Also known as: LMBB
ultrasound guided infiltration verified by fluoroscopy

Linisol infiltration with depomedrol and omnipaque

Also known as: linisol
ultrasound guided infiltration verified by fluoroscopy

infiltration with linisol and omnipaque

Also known as: solumedrol
ultrasound guided infiltration verified by fluoroscopy

infiltration with linisol and methylprednisolone

ultrasound guided infiltration verified by fluoroscopy

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • chronic low back pain compatible with facet lumbar syndrome with chronic pain of at least 3 months
  • who have not responded to conservative treatment after at least 4 weeks
  • patients without signs of dissociated pain, radiculitis, neurological diseases including stroke and Parkinson's disease, spinal instability or deformities such as scoliosis, ankylosing spondylitis, history of lumbar surgery, fracture or lumbar tumor

You may not qualify if:

  • Pregnant or breastfeeding women
  • Allergy to injected products (Depomedrol or Linisol)
  • Psychiatric disorders hindering understanding of the protocol
  • Local or systemic infection
  • Coagulation disorder
  • Obese with a BMI\> 35 kg / m²

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital Erasme

Brussels, 1070, Belgium

RECRUITING

MeSH Terms

Conditions

PainBronchiolitis Obliterans Syndrome

Interventions

MethylprednisoloneMethylprednisolone HemisuccinateIohexol

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsOrganizing PneumoniaBronchiolitis ObliteransBronchiolitisBronchitisBronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesGraft vs Host DiseaseImmune System Diseases

Intervention Hierarchy (Ancestors)

PrednisolonePregnadienetriolsPregnadienesPregnanesSteroidsFused-Ring CompoundsPolycyclic CompoundsTriiodobenzoic AcidsIodobenzoatesBenzoatesAcids, CarbocyclicCarboxylic AcidsOrganic ChemicalsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbons

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: the medial branch block on three lumbar levels (L3-L4, L4-L5 and L5-S1) will be performed under ultrasound by "caudal-cranial" approach, followed by an X-ray check to verify the positioning of the needle.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Nisolle Marie-Laure, MD

Study Record Dates

First Submitted

June 22, 2023

First Posted

July 5, 2023

Study Start

April 21, 2023

Primary Completion

June 1, 2024

Study Completion

June 1, 2024

Last Updated

July 5, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

Locations